ReviewFrontiers in medicine2025
Clinical outcomes of a hydrophobic trifocal diffractive intraocular lens: a literature review.
Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Clinical Outcomes of Double C-Loop Haptic Intraocular Lenses Across Different Optic Designs: A Retrospective Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Clinical Outcomes of the First Diffractive Trifocal Intraocular Lens: A Literature Review.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
- Bilateral Refractive Lens Exchange with a Hydrophobic Trifocal Intraocular Lens.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- First Clinical Results of a Multicentric Prospective Study on the Visual Performance of Patients Implanted with a New Trifocal Aspheric Hydrophobic Intraocular Lens.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Visual Outcomes and Patient Satisfaction with Extended Monovision-An Innovative Strategy to Achieve Spectacle Independence in Refractive Lens Exchange.Journal of clinical medicine · 2025Article
- Visual and Refractive Outcomes of a Hydrophobic Trifocal Diffractive Intraocular Lens in Eyes with Different Axial Lengths.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this review is to summarize the clinical outcomes reported in patients following the implantation of the hydrophobic diffractive trifocal FineVision HP intraocular lens (IOL). A literature search in PubMed (U.S. National Library of Medicine) was performed to identify publications, both prospective and retrospective, which have reported the clinical outcomes of patients who were implanted with this IOL model after cataract or refractive lens exchange surgeries. A total of 18 clinical studies published between 2019 and 2024 were included in this review. The available data reported in the different clinical publications was analyzed in detail, focusing mainly on refraction, visual acuity, the defocus curve, optical quality, contrast sensitivity, and patient-reported outcome questionnaires. In addition, the adverse events and other measurements reported in some studies were also analyzed. Our review encompassed a total of 1,028 eyes analyzed at different follow-up periods up to a maximum of 24 months. The analysis carried out in this review leads us to conclude that the FineVision HP IOL provides good refractive outcomes and excellent visual performance when implanted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.